Femasys vs Renovorx
Femasys is the larger business, with $2.3m of revenue in fiscal 2025 against $1.1m for Renovorx (2.0 times as much). Renovorx grew faster (2511.6% against 40.8%). Femasys kept more of each dollar of sales as profit: a net margin of -812.3% against -994.5%.
| Latest fiscal year | FemasysFEMY, 2025 | RenovorxRNXT, 2025 |
|---|---|---|
| Revenue | $2.3m | $1.1m |
| Revenue growth | 40.8% | 2511.6% |
| Net income | −$18.6m | −$11.2m |
| Operating margin | -767.0% | — |
| Net margin | -812.3% | -994.5% |
| Return on equity | — | — |
| Free cash flow | −$19.2m | −$11.0m |
| Cash | $9.3m | $7.0m |
| Total debt | $3.2m | $0 |
| Debt to equity | 54.2% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 51 | 17 |
| Market value | $4.1m | $57.8m |
| Price vs our value range | — | — |
| Moat score | 37 (Weak) | — |
| Insider trades, 12 months | 5 buys, 0 sales | 13 buys, 0 sales |